Read more about Allergan Announces FDA Approval of BYVALSON™ (nebivolol and valsartan)

Allergan plc announced the approval of BYVALSON™ (nebivolol and valsartan) 5 mg/ 80 mg tablets, by the U.S. Food and Drug Administration (FDA) for the treatment of hypertension to lower blood pressure. BYVALSON is the first and only fixed-dose combination (FDC) of a beta blocker (BB) and angiotensin II receptor blocker (ARB) available in the U.S.

8 June 2016

Job as Bioresearch Quality & Compliance Pharmacovigilance Manager in Johnson & Johnson

Caring for the world, one person at a time... inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Employees of the Johnson & Johnson Family of Companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

Read more about Amgen launches Kyprolis Central, an online media resource

Amgen announced the launch of Kyprolis Central, an online media resource about the impact of living with relapsed or refractory multiple myeloma. Intended to drive awareness of a rare blood cancer that is increasingly becoming more prevalent in the United States (US), Kyprolis Central provides real-life stories from relapsed multiple myeloma patients, as well as educational materials and third party resources.

Read more about FDA give Complete Response Letter to Adamis Pharmaceuticals Epinephrine Pre-Filled Syringe NDA

Adamis Pharmaceuticals Corporation announced that after the close of the stock markets on June 3, 2016 it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) Epinephrine Injection USP 1:1000 0.3mg Pre-filled Single Dose Syringe (PFS) product. PFS is for the emergency treatment of acute anaphylaxis, which is a severe allergic reaction. A CRL is issued by the FDA's Center for Drug Evaluation and Research when it has

Read more about Merck & Lilly products show positive results in Early-Phase Immuno-Oncology Studies

Eli Lilly and Company announced that clinical study data from two of its ongoing immuno-oncology clinical collaborations with Merck were presented this weekend at the 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO). Specifically, data were presented from two early-phase trials evaluating ALIMTA® (pemetrexed)-plus-carboplatin and CYRAMZA® (ramucirumab), respectively, in combination with Merck's KEYTRUDA® (pembrolizumab), in patients with non-small cell lung cancer (NSCLC).

Submitted by admin on 7 June 2016

Forums

Latest Updates in Pharmacy

NPPA cut prices of 64 medicines - Read more

Notified ceiling prices of 25 scheduled formulations of Schedule-I under Drugs (Price Control) Amendment Order, 2016.

Read more about Lists of 64 formulations which price cut by NPPA
1 comment
Log in to post comments

7 June 2016

Recruitment for Jr. Pharmacist (49 posts) in JKSSB - Govt Job

The Services Selection Board has been constituted in exercise of powers conferred by Provision of Section 124 of the Constitution of Jammu and Kashmir. Pursuant to Section 15 of J&K Civil Services Decentralisation and Recruitment Act 2010, the Rules have been made/notified under SRO 375 of 2010 dated 21-10-2010. The Chairman, Members and Secretary of the Board are deputed/nominated by the government from amongst the in-service IAS/KAS Officers or the persons of high repute in the field of education as per rules, the selection/ recruitment to Non-Gazetted categories of posts falls within ambit of Services Selection Board

Post: Jr. Pharmacists

Read more about NPPA cut prices of 64 medicines

National Pharmaceuticals Pricing Authority (NPPA) has fixed prices of 64 important drug formulations and I.V. Fluids which are used for life threatening diseases or disorders like cancer, diabetes, cardio vascular diseases, pain killers, bacterial infections (antibiotics) etc.

7 June 2016

Recruitment For Paramedical Staff in COLLEGE OF HORTICULTURE, MULDE

Applications are invited from the eligible candidates for the following posts purely temporary and on contract basis in the scheme “College of Horticulture, Mulde” implemented in the University. Candidates are here by informed to submit the application on or before 17 June, 2016 in the office of The Associate Dean, College of Horticulture, Mulde, Tal. Kudal, Dist – Sindhudurg. However, the interview will be conducted on 24 June, 2016 at the office of the College of Horticulture, Mulde, Tal. Kudal, Dist – Sindhudurg.

Post: Nurse-01, Compounder-01

7 June 2016

Wanted Deputy Manager / Manager - Program Management R&D at Hospira

Hospira is the world's leading provider of injectable drugs and infusion technologies. Through our broad, integrated portfolio, we are uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs.
Through our offering of high-quality, lower-cost generic medications, we continue to help reduce the overall costs of healthcare — to improve both the affordability of care for patients and the financial strength of the global healthcare system.

Post: Deputy Manager / Manager - Program Management R&D

Search

June 2016

NPPA cut prices of 64 medicines - Read more

RECOMMENDED POSTS

Subscribe with us

Jobs by Category